Davidson & Garrard’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Davidson & Garrard’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-20,410	Closed	-$1.27M	–	190
2015 Q2	$1.27M	Sell	20,410 -2,238	-10%	-$139K	0.3%	100
2015 Q1	$1.4M	Buy	22,648 +510	+2%	+$30.2K	0.32%	94
2014 Q4	$1.2M	Buy	22,138 +2,680	+14%	+$146K	0.28%	97
2014 Q3	$1.03M	Sell	19,458 -150	-0.8%	-$7.63K	0.25%	105
2014 Q2	$1.02M	Sell	19,608 -380	-2%	-$18.3K	0.24%	105
2014 Q1	$936K	Buy	19,988 +250	+1%	+$11.8K	0.23%	107
2013 Q4	$868K	Sell	19,738 -432	-2%	-$18K	0.22%	112
2013 Q3	$776K	Buy	20,170 +2,800	+16%	+$106K	0.22%	108
2013 Q2	$612K	Buy	+17,370	New	+$586K	0.18%	110

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Davidson & Garrard's XPH Position: Q3 2015 in Review

Davidson & Garrard sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 20,410 shares — an estimated $1.27M sold.

Davidson & Garrard first reported a position in XPH in Q2 2013 and held it in 9 quarters. The position peaked at $1.4M in Q1 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

Davidson & Garrard reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Davidson & Garrard sold 20,410 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $1.27M.
Davidson & Garrard first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 9 quarters.
Davidson & Garrard's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.4M in Q1 2015.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on Davidson & Garrard's 13F filing for Q3 2015, filed 6 Nov 2015.